Showing results (1621-1630 of 2,669) with videos related to
Sort By:
Pageof 267
Oncology Research|October 6, 2025
Deubiquitinating Enzyme OTUDs: Focus on Cancers and Antiviral ResponseLang Chen, Rui Dong, Xuan HuanOncology Research|October 6, 2025
Predictive Value of Serum VEGF Levels in Non-Small Cell Lung Cancer: A ReviewEleni Kokkotou, Andriani Charpidou, Nikolaos SyrigosOncology Research|October 6, 2025
Igniting Cold Tumors: Multi-Omics-Driven Strategies to Overcome Immune Evasion and Restore Immune SurveillanceXinyao Huang, Renjun Gu, Ziyun Li, et al.Oncology Research|November 3, 2025
Significance of CA125 Monitoring during Maintenance Treatment with Poly(ADP-Ribose) Polymerase Inhibitor in Ovarian Cancer after First-Line Chemotherapy: Multicenter, Observational StudySzymon Piątek, Anna Dańska-Bidzińska, Paweł Derlatka, et al.Oncology Research|November 3, 2025
Exosomal Non-Coding RNAs in Pancreatic Cancer: From Mechanisms to Clinical ApplicationsChengru Yang, Zhiyu Wang, Shaowu Bi, et al.Oncology Research|November 3, 2025
Construction of a Prognostic Model of Prostate Cancer Based on Immune and Metabolic Genes and Experimental Validation of the Gene AK5Wenjie Zhou, Jiawei Ding, Danfeng XuOncology Research|October 6, 2025
NLR Risk Score for Predicting Patient Prognosis in Hepatocellular Carcinoma and Identification of Oncogenic Role of NLRP5 in Hepatocellular CarcinomaMingyang Tang, Shengfu He, Bao Meng, et al.Oncology Research|October 6, 2025
Topical Chemotherapy for Ocular Surface Squamous Neoplasia: A Review of Adverse Effects and Their Clinical ManagementLina Corgiolu, Giuseppe Giannaccare, Alberto CuccuOncology Research|July 4, 2025
SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancersQian Li, Shunpeng Zhu, Mingxian Zhu, et al.Pageof 267